
Nanobots Market Report By Type of Nanobot (Biological Nanobots, Mechanical Nanobots, Molecular Nanobots, Hybrid Nanobots, Others), By Application (Medical Nanobots, Environmental Nanobots, Defense and Security Nanobots, Industrial Nanobots, Research Nanobots, Others), By Type of Manufacturing (Biochips, Nubots, Bacteria-based Nanobots, 3D Printing, Other Types), By End User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
-
46578
-
May 2024
-
291
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Quick Navigation
Report Overview
The Global Nanobots Market size is expected to be worth around USD 31.6 billion by 2033, from USD 7.2 billion in 2023, growing at a CAGR of 16.4% during the forecast period from 2024 to 2033.
The nanobots market involves tiny robots, often at a microscopic scale, designed for specific tasks in medical and industrial fields. These devices are revolutionizing healthcare by enabling targeted drug delivery, precise surgical procedures, and advanced diagnostics. In industries, nanobots contribute to improved manufacturing processes and material science innovations.
The growth of this market is fueled by advancements in nanotechnology, increasing investments in research and development, and the rising demand for minimally invasive medical procedures. Companies are exploring the vast potential of nanobots to enhance efficiency and achieve breakthroughs in various applications.
The nanobots market is experiencing rapid growth, driven by advancements in nanotechnology and increasing applications in healthcare, environmental monitoring, and military technology. Nanobots, tiny robots designed to perform specific tasks at the nanoscale, are revolutionizing various sectors due to their precision and versatility.
In February 2024, notable innovations included injectable nanobots for targeted drug delivery, SlothBot for ecological research, and Xenobots made from frog cells. These developments highlight the diverse potential of nanobots in medical, environmental, and military applications. The ability of injectable nanobots to deliver drugs directly to specific sites in the body represents a significant advancement in personalized medicine, improving treatment efficacy and reducing side effects.
Furthermore, in September 2023, MIT researchers developed nanobots like the Cell Rover, capable of entering brain cells to detect and potentially treat neurological disorders such as Alzheimer's and Parkinson's. This breakthrough offers promising advancements in medical diagnostics and treatment, showcasing the potential of nanobots to address complex medical challenges at the cellular level.
The growing demand for precision medicine and advanced diagnostics is propelling the nanobots market forward. These tiny robots provide unprecedented accuracy in targeting and treating diseases, making them invaluable in modern healthcare. Additionally, the environmental applications of nanobots, such as ecological research and monitoring, further underscore their versatility and potential for broader societal impact.
In conclusion, the nanobots market is set for significant growth, driven by continuous technological innovations and expanding applications across various fields. The advancements in medical nanobots, coupled with their potential in environmental and military sectors, highlight the promising future of this emerging market.
Key Takeaways
- Market Value: The Global Nanobots Market is expected to grow from USD 7.2 billion in 2023 to around USD 31.6 billion by 2033, at a CAGR of 16.4% during 2024-2033.
- Biological Nanobots Analysis: Dominates with 45% share due to medical applications; significant potential in targeted drug delivery.
- Mechanical Nanobots Analysis: Essential in industrial applications; contribute to manufacturing and maintenance processes.
- Molecular Nanobots Analysis: Potential in medical and environmental fields; smaller market share due to ongoing research.
- Hybrid Nanobots Analysis: Emerging as versatile nanobots; combine biological and mechanical features for enhanced functionality.
- Dominant Region: Europe leads with 37.3% market share; pivotal in nanobot research and development.
- High Growth Region: North America holds 32.8% share; increasing adoption in medical and defense applications.
- Analyst Viewpoint: The nanobots market shows strong growth prospects driven by expanding applications in healthcare, industry, and defense. Ongoing research and development are crucial for sustaining market growth.
- Growth Opportunities: Key players can leverage advancements in hybrid nanobots and 3D printing technology to innovate and gain competitive advantage in the market.
Driving Factors
Advancements in Nanotechnology Drives Market Growth
The rapid evolution of nanotechnology is a key driver of the nanobots market. This technology's ability to manipulate materials at the atomic level has significantly expanded the capabilities of nanobots. For example, DNA-based nanobots developed by researchers at the University of California, Berkeley, showcase the potential to deliver therapeutic molecules directly to specific body sites, enhancing precision in medical treatments.
This technological leap facilitates the creation of more complex and effective nanobots, which are being increasingly integrated across various sectors, not limited to healthcare. As these advancements continue, the market for nanobots is expected to grow, supported by ongoing research and development efforts that push the boundaries of what nanobots can achieve.
Healthcare Applications Drive Market Growth
Nanobots in the healthcare sector present substantial growth opportunities for the market. These microscopic devices offer breakthrough methods in drug delivery, anti cancer drugs, and diagnostic processes, significantly enhancing treatment precision and efficacy. For instance, MIT's development of nanobots that selectively target cancer cells exemplifies this potential.
These advancements lead to improved patient outcomes and reduced healthcare costs, propelling market expansion. The integration of nanobots into healthcare systems is driven by the critical need for more effective treatment modalities and the ongoing research that supports the practical implementation of these technologies.
Environmental Remediation Drives Market Growth
The application of nanobots in environmental remediation marks another significant growth vector for the market. These nanobots are engineered to address pollution by neutralizing or removing contaminants from ecosystems, which is essential for maintaining environmental health and safety.
The development of pollutant-targeting nanobots at the University of California, San Diego, demonstrates their effectiveness in cleaning water sources, breaking down hazardous substances into non-toxic components. The growing global focus on sustainability and environmental preservation is likely to boost the demand for such innovative solutions, positioning nanobots as crucial tools in combating ecological threats and supporting the market's upward trajectory.
Restraining Factors
Technological Limitations Restrain Market Growth
Technological limitations significantly restrain the growth of the nanobots market. Despite advances, challenges remain in controlling and powering nanobots, ensuring stability, and managing their interactions with biological systems and the environment. Efficient and long-lasting power sources are still under development, which limits the operational capabilities of nanobots.
Stability issues also arise, as nanobots must function reliably within complex biological or environmental systems. These technological hurdles slow down the adoption of nanobots, as ongoing research is required to overcome these barriers. Without addressing these issues, the widespread implementation of nanobots remains a significant challenge for the market.
Safety and Ethical Concerns Restrain Market Growth
Safety and ethical concerns are major barriers to the growth of the nanobots market. Potential risks include toxicity, bioaccumulation, and unintended consequences, particularly in healthcare and environmental applications. Ethical issues also emerge, such as the use of nanobots for surveillance or military purposes.
The potential misuse of nanobots for unauthorized surveillance or as weapons of mass destruction raises significant ethical questions. These concerns lead to regulatory challenges and public skepticism, slowing down the acceptance and integration of nanobots into mainstream applications. Addressing these safety and ethical issues is crucial for the market to gain wider acceptance and trust.
Type of Nanobot Analysis
Biological Nanobots dominate with 45% due to their potential in medical applications.
The biological nanobots segment holds the dominant position in the nanobots market, driven primarily by their significant potential in medical applications. Biological nanobots, designed using organic molecules like DNA or proteins, exhibit high compatibility with biological systems. Their ability to perform specific tasks within the human body, such as targeted drug delivery, makes them highly valuable. For instance, DNA-based nanobots developed for targeted cancer therapy demonstrate a major advancement in this field, offering precise treatment options with minimal side effects. This capability has led to substantial investment and research focus, cementing their dominant market position with a 45% share.
Mechanical nanobots, while less dominant, play a crucial role in various industrial applications. These nanobots, constructed from inorganic materials, are engineered to perform mechanical tasks, such as assembling structures at the nanoscale. They are essential in manufacturing and maintenance processes, where precision and durability are required. Although their market share is smaller, mechanical nanobots contribute significantly to industrial efficiency and technological advancements.
Molecular nanobots, designed to manipulate molecules at the atomic level, have shown promise in both medical and environmental applications. They are capable of detecting and repairing cellular damage, which is crucial for advanced medical treatments. In environmental settings, they can break down pollutants at the molecular level, aiding in remediation efforts. Despite their potential, they currently hold a smaller market share due to ongoing research and development challenges.
Hybrid nanobots, combining features of biological and mechanical nanobots, are emerging as a versatile segment. These nanobots leverage the strengths of both types, offering enhanced functionality and adaptability. They are being explored for complex tasks in various fields, including healthcare and environmental remediation. As research progresses, hybrid nanobots are expected to gain a larger market share, contributing to the overall growth of the nanobots market.
The "Others" category includes experimental and niche nanobots that do not fit into the primary categories. These nanobots are often in the early stages of development and are being explored for unique applications. While their current market impact is limited, they represent a potential area for future growth and innovation in the nanobots market.
Application Analysis
Medical Nanobots dominate with 60% due to their transformative impact on healthcare.
Medical nanobots are the leading segment in the nanobots market, accounting for a significant 60% share. This dominance is attributed to their transformative impact on healthcare. Medical nanobots offer revolutionary solutions in areas such as targeted drug delivery, minimally invasive surgery, and advanced diagnostics. For instance, nanobots capable of delivering chemotherapy drugs directly to cancer cells can significantly reduce side effects and improve treatment outcomes. These advancements have driven substantial investment and research efforts, solidifying the position of medical nanobots as the market leader.
Environmental nanobots, although less dominant, play a critical role in addressing ecological challenges. These nanobots are designed to detect and neutralize pollutants, clean up oil spills, and even capture microplastics from water sources. Their application in environmental remediation is gaining traction as the global focus on sustainability and environmental preservation intensifies. Despite their smaller market share, environmental nanobots contribute significantly to market growth through their unique and essential capabilities.
Defense and security nanobots represent a growing segment within the market. These nanobots are developed for applications such as surveillance, detection of hazardous materials, and even offensive measures. Their ability to operate in challenging environments makes them valuable for military and security operations. As advancements in nanotechnology continue, this segment is expected to expand, driven by increased defense budgets and the need for advanced security solutions.
Industrial nanobots are used in manufacturing, maintenance, and quality control processes. These nanobots enhance precision and efficiency, leading to cost savings and improved product quality. They are particularly valuable in sectors such as electronics, where nanoscale assembly and repair are critical. While their market share is currently modest, industrial nanobots are poised for growth as industries continue to adopt advanced manufacturing technologies.
Research nanobots, employed in scientific studies and experiments, are essential for advancing nanotechnology. They enable researchers to explore new applications and improve existing technologies. Although this segment holds a smaller market share, it is crucial for the ongoing development and innovation within the nanobots market.
The "Others" category includes niche applications and experimental uses of nanobots that do not fall into the primary categories. These applications are often in the early stages of development but represent potential future growth areas for the nanobots market.
Type of Manufacturing Analysis
Biochips dominate with 50% due to their integration in medical and research applications.
The biochips segment is the leading manufacturing type in the nanobots market, accounting for 50% of the share. Biochips are essential for creating biological nanobots, which are widely used in medical and research applications. These chips facilitate the integration of biological components with electronic systems, enabling advanced functionalities such as real-time monitoring and precise control of biological processes. The extensive use of biochips and lab on chip in developing DNA-based nanobots for targeted therapies highlights their critical role in the market.
Nubots, or nucleic acid robots, are an emerging segment with significant potential. These nanobots, constructed from nucleic acids like DNA, are designed for highly specific tasks within biological systems. Their ability to interact with genetic material makes them valuable for applications such as gene therapy and molecular diagnostics. As research in this area progresses, the market share of nubots is expected to grow, driven by their unique capabilities and expanding application scope.
Bacteria-based nanobots leverage natural bacterial mechanisms for various applications. These nanobots can be engineered to perform tasks such as targeted drug delivery, biosensing, and environmental remediation. Their natural adaptability and efficiency make them an attractive option for specific applications. Although their market share is currently smaller, bacteria-based nanobots are gaining attention for their potential to address complex biological and environmental challenges.
3D printing is revolutionizing the manufacturing of nanobots by enabling the precise fabrication of complex structures. This technology allows for the creation of custom nanobots tailored to specific applications, enhancing their functionality and performance. The flexibility and precision offered by 3D printing are driving its adoption in the nanobots market. As 3D printing technology continues to advance, its market share is expected to increase, contributing to the overall growth of the nanobots market.
The "Other Types" category includes experimental manufacturing methods that are still in the early stages of development. These methods offer innovative approaches to nanobot fabrication and hold potential for future market expansion. While their current impact is limited, ongoing research and technological advancements could lead to significant contributions from this segment in the future.
End User Analysis
Healthcare Providers dominate with 55% due to the high demand for advanced medical technologies.
Healthcare providers are the dominant end-users in the nanobots market, accounting for 55% of the share. The high demand for advanced medical technologies, such as targeted drug delivery and minimally invasive procedures, drives the adoption of nanobots in healthcare settings. Nanobots offer significant benefits in terms of treatment precision, patient outcomes, and cost-effectiveness. For example, nanobots capable of detecting and treating cancer cells at an early stage can dramatically improve survival rates and reduce healthcare costs. This strong demand from healthcare providers supports the dominant position of this segment in the market.
Pharmaceutical companies are key end-users of nanobots, utilizing them for drug development, delivery, and personalized medicine. Nanobots enable precise targeting and controlled release of therapeutics, enhancing the efficacy and safety of medications. The integration of nanobots into pharmaceutical processes helps in overcoming drug delivery challenges and optimizing treatment regimens. Although their market share is smaller than healthcare providers, pharmaceutical companies play a crucial role in driving innovation and market growth.
Environmental agencies employ nanobots for pollution detection and remediation. These agencies leverage nanobots to address environmental challenges such as water and soil contamination. The ability of nanobots to operate at the nanoscale allows for efficient removal of pollutants and restoration of ecosystems. As global environmental concerns rise, the demand for nanobots in this segment is expected to increase, contributing to market expansion.
Defense and military applications of nanobots include surveillance, detection of hazardous materials, and advanced weaponry. Nanobots offer unique capabilities in these areas, enhancing the effectiveness and safety of military operations. The adoption of nanobots by defense and military organizations is driven by the need for cutting-edge technology to address emerging threats. While this segment currently holds a smaller market share, it is poised for growth as defense budgets and technological investments rise.
Research institutes and universities utilize nanobots for scientific studies and innovation. These institutions are at the forefront of nanobot research, exploring new applications and refining existing technologies. The contributions of research institutes are critical for advancing the field and driving market growth. Although their market share is modest, research institutes and universities play a vital role in the ongoing development and commercialization of nanobots.
The "Others" category includes niche end-users and experimental applications that do not fall into the primary categories. These end-users often explore unique and innovative uses for nanobots, contributing to the diversification and expansion of the market. While their current impact is limited, they represent potential growth areas for the future of the nanobots market.
Key Market Segments
By Type of Nanobot
- Biological Nanobots
- Mechanical Nanobots
- Molecular Nanobots
- Hybrid Nanobots
- Others
By Application
- Medical Nanobots
- Environmental Nanobots
- Defense and Security Nanobots
- Industrial Nanobots
- Research Nanobots
- Others
By Type of Manufacturing
- Biochips
- Nubots
- Bacteria-based Nanobots
- 3D Printing
- Other Types
By End User
- Healthcare Providers
- Pharmaceutical Companies
- Environmental Agencies
- Defense and Military
- Research Institutes and Universities
- Others
Growth Opportunities
Targeted Drug Delivery Offers Growth Opportunity
Nanobots provide a unique chance for improving drug delivery systems. They can precisely target specific cells, tissues, or organs, enhancing the efficacy and safety of treatments. This precision minimizes systemic side effects and increases the therapeutic index.
For example, researchers at MIT are developing nanorobotic systems to navigate through the bloodstream and release drugs at tumor sites. This innovation could revolutionize cancer treatment by delivering chemotherapy directly to cancer cells, reducing damage to healthy tissues. The ability to target drug delivery so accurately makes nanobots a valuable tool in modern medicine, driving growth in the market.
Regenerative Medicine and Tissue Engineering Offer Growth Opportunity
Nanobots hold significant promise in regenerative medicine and tissue engineering. They can deliver stem cells, growth factors, or other regenerative materials to specific body sites, aiding in tissue repair and regeneration.
Researchers are exploring nanobots to deliver stem cells and guide tissue regeneration in patients with spinal cord injuries. Additionally, nanobots can construct intricate nanostructures or scaffolds for tissue engineering, creating opportunities for advanced medical treatments. This potential to repair and regenerate damaged tissues positions nanobots as key players in the future of regenerative medicine, supporting market expansion.
Trending Factors
Biomedical Applications Are Trending Factors
The biomedical field is a major driver of nanobot development and adoption. The increasing demand for personalized and targeted therapies, along with early and accurate diagnostic tools, makes nanobots highly promising. Research focuses on applications such as targeted drug delivery, molecular imaging, and minimally invasive surgeries.
For example, researchers at the University of California, San Francisco, are using nanobots for non-invasive brain tumor diagnosis and treatment. This trend towards innovative biomedical applications highlights the significant role of nanobots in advancing medical technology and improving patient care, driving market growth.
Miniaturization and Nanorobotics Are Trending Factors
The trend towards miniaturization and nanorobotics fuels the nanobots market's growth. Advances in technology enable the creation of smaller and more sophisticated nanobots with enhanced capabilities. These tiny robots can access and interact with systems at the molecular level, opening up new possibilities in medicine, environmental remediation, and materials science.
Researchers at the University of Pennsylvania are developing nanorobotic systems that navigate complex environments and perform nanoscale tasks. This trend towards miniaturization enhances the functionality and application range of nanobots, positioning them as critical tools in various industries and driving market expansion.
Regional Analysis
Europe Dominates with 37.3% Market Share
Europe holds a 37.3% share of the nanobots market. This dominance is driven by strong research and development efforts, extensive funding, and a robust healthcare infrastructure. European countries, particularly Germany, the UK, and France, invest heavily in nanotechnology. This investment supports the development and commercialization of nanobots, particularly in healthcare and environmental applications.
Europe's leadership in nanobots is due to substantial R&D funding, advanced technological infrastructure, and strong collaboration between academic institutions and industry. The European Union's Horizon 2020 program has significantly boosted nanotechnology research. Additionally, the region's regulatory framework supports innovation while ensuring safety and ethical standards. These factors collectively enhance Europe's market position in the nanobots industry.
Regional Market Share
- North America: Holds 32.8% of the market share. Strong technological advancements and significant investment in healthcare applications drive growth. The presence of leading nanotechnology companies and research institutions supports market expansion.
- Asia Pacific: Accounts for 22.5% of the market share. Rapid industrialization, increasing healthcare expenditures, and growing environmental concerns propel market growth. Countries like China and Japan are major contributors.
- Middle East & Africa: Holds a smaller share of 4.6%. The market is growing due to increasing investments in healthcare infrastructure and technological innovation. However, the growth rate is slower compared to other regions.
- Latin America: Accounts for 2.8% of the market share. The market is expanding gradually with rising investments in healthcare and environmental projects. Brazil and Mexico are key contributors to regional growth.
Key Regions and Countries
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
The Nanobots Market is shaped by a consortium of influential players, each demonstrating strategic prowess and market influence through their distinct capabilities. Foremost, companies like Zymergen Inc., Ginkgo Bioworks, and Synthace are spearheading innovations in synthetic biology and automation technologies, positioning them as leaders in driving forward the development and application of nanobots.
Thermo Fisher Scientific Inc., with its subsidiaries such as FEI Company, underscores its market dominance by providing comprehensive technological solutions across various sectors, enhancing its global footprint. Similarly, Bruker Corporation and JEOL Ltd. contribute significantly through high precision instruments that cater to advanced research needs in nanotechnology.
Emerging players such as Oxford Nanopore Technologies and Imina Technologies SA are notable for their specialized focus on nanoscale measurements and analysis, which cater to niche markets within healthcare and material sciences, thereby securing their strategic positions.
Additionally, companies like Kleindiek Nanotechnik GmbH and Nanonics Imaging Ltd. are vital for their innovative approaches to nanopositioning and imaging technologies, which are essential for the progression of nanoscale interventions.
The collective efforts of these companies not only promote technological advancements but also foster a competitive environment that propels market growth. Their strategic positioning, coupled with ongoing investments in R&D and global alliances, robustly shapes the landscape of the Nanobots Market, ensuring sustained impact and market expansion.
Market Key Players
- Zymergen Inc.
- Ginkgo Bioworks
- Synthace
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies
- Imina Technologies SA
- Kleindiek Nanotechnik GmbH
- Bruker Corporation
- JEOL Ltd.
- FEI Company (part of Thermo Fisher Scientific)
- Agilent Technologies, Inc.
- Park Systems
- Nanonics Imaging Ltd.
- Novasentis, Inc.
- Nanonets
Recent Developments
- February 2024: Innovative robots, including injectable nanobots for drug delivery, SlothBot for ecological research, and Xenobots made from frog cells. These robots demonstrate advancements in medical, environmental, and military technology, providing diverse applications for future development.
- January 2024: Researchers develop urease-powered nanobots for highly effective radionuclide therapy in bladder cancer. These 450 nm nanobots navigate urine flow, achieving 8-fold higher tumor concentrations via active dispersion, validated in mice models.
- December 2023: Researchers have developed nanoscale robots made of DNA that exponentially self-replicate, paving the way for drug and chemical manufacturing inside the body. These 100 nm machines use DNA strands to build 3D structures error-free.
- September 2023: Nanobots developed by MIT researchers, such as the Cell Rover, can enter brain cells to detect and potentially treat neurological disorders like Alzheimer's and Parkinson's. This breakthrough technology, as of September 2023, offers promising advancements in medical diagnostics and treatment.
Report Scope
Report Features Description Market Value (2023) USD 7.2 Billion Forecast Revenue (2033) USD 31.6 Billion CAGR (2024-2033) 16.4% Base Year for Estimation 2023 Historic Period 2018-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered By Type of Nanobot (Biological Nanobots, Mechanical Nanobots, Molecular Nanobots, Hybrid Nanobots, Others), By Application (Medical Nanobots, Environmental Nanobots, Defense and Security Nanobots, Industrial Nanobots, Research Nanobots, Others), By Type of Manufacturing (Biochips, Nubots, Bacteria-based Nanobots, 3D Printing, Other Types), By End User (Healthcare Providers, Pharmaceutical Companies, Environmental Agencies, Defense and Military, Research Institutes and Universities, Others) Regional Analysis North America - The US, Canada, & Mexico; Western Europe - Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe - Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC - China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America - Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa - Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Zymergen Inc., Ginkgo Bioworks, Synthace, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Imina Technologies SA, Kleindiek Nanotechnik GmbH, Bruker Corporation, JEOL Ltd., FEI Company (part of Thermo Fisher Scientific), Agilent Technologies, Inc., Park Systems, Nanonics Imaging Ltd., Novasentis, Inc., Nanonets Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
-